Circulation Research, Vol 66, 176-184, Copyright © 1990 by American Heart Association
ARTICLES |
Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats
H Matsubara, J Yamamoto, Y Hirata, Y Mori, S Oikawa and M Inada
Department of Medicine, Kansai Medical University, Moriguchi, Japan.
We assessed the changes in atrial natriuretic peptide (ANP) and its messenger RNA (mRNA) levels in atria and ventricles in relation to hemodynamic factors during antihypertensive treatments in two-kidney, one-clip renovascular hypertensive rats (RHRs). Hypertension of 10-week duration caused a twofold increase in the left ventricular weight/body weight ratio, a significant increase in left ventricular end-diastolic pressure, and an eightfold increase in left ventricular ANP mRNA levels in RHRs, as compared with the levels in control rats. Uninephrectomy or 4 weeks of treatment with the converting enzyme inhibitor enalapril reduced the blood pressure to the control level, with the complete reversal of left ventricular hypertrophy, left ventricular end- diastolic pressure, and ANP mRNA levels. Four weeks of treatment with the arterial vasodilator hydralazine significantly, but not completely, reduced the high blood pressure, but it did not influence left ventricular hypertrophy, end-diastolic pressure, and ANP mRNA levels. The increased ANP synthesis observed in the right ventricles of RHRs also reverted to the control level by uninephrectomy or enalapril treatment, but not by hydralazine, with a time course similar to that of left ventricular ANP. In addition, uninephrectomy caused the left and right ventricular ANP and ANP mRNA levels of RHRs to fall to the levels of control rats as early as 1 week, despite persistent left ventricular hypertrophy.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
 |
|
 |
|
  K. S. Lee, S. Y. Kim, J. H. Han, Y. A. Kim, C. Cao, S. Z. Kim, K. W. Cho, and S. H. Kim Different Responses of Atrial Natriuretic Peptide Secretion and Its Receptor Density to Salt Intake in Rats Experimental Biology and Medicine, January 1, 2004; 229(1): 65 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Kim, J. H. Han, S. H. Lim, S. J. Lee, S. Z. Kim, and K. W. Cho Attenuation of inhibitory effect of CNP on the secretion of ANP from hypertrophied atria Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1456 - R1463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Brunner Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat Cardiovasc Res, October 1, 1999; 44(1): 197 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Partovian, S. Adnot, S. Eddahibi, E. Teiger, M. Levame, P. Dreyfus, B. Raffestin, and C. Frelin Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H1948 - H1956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Vikstrom, T. Bohlmeyer, S. M. Factor, and L. A. Leinwand Hypertrophy, Pathology, and Molecular Markers of Cardiac Pathogenesis Circ. Res., April 20, 1998; 82(7): 773 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ogawa, W. Linz, M. Stevenson, B. G. Bruneau, M. L. Kuroski de Bold, J. H. Chen, H. Eid, B. A. Scholkens, and A. J. de Bold Evidence for Load-Dependent and Load-Independent Determinants of Cardiac Natriuretic Peptide Production Circulation, June 1, 1996; 93(11): 2059 - 2067. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Murasawa, H. Matsubara, K. Kizima, K. Maruyama, Y. Mori, and M. Inada Glucocorticoids Regulate V1a Vasopressin Receptor Expression by Increasing mRNA Stability in Vascular Smooth Muscle Cells Hypertension, October 1, 1995; 26(4): 665 - 669. [Abstract] [Full Text]
|
|